Product Liability

December 7, 2009

Fort Worth Texas Yaz Yasmin Birth Control Lawsuit Update

After 13 hours of intensifying pain, two trips to the emergency room and two CT scans, doctors finally found what was ailing Lottie Green.

In her left lung, the pulmonologist told her, was the largest blood clot they had ever seen and there were others in her right lung as well, she said.

Soon after the 41-year-old Bethesda, Md., resident was released from a hospital last month, Ms. Green joined hundreds of other women in lawsuits against Germany’s Bayer AG, the maker of the popular oral contraceptive Yaz.

December 6, 2009

FDA Review Says MRI Imaging Drugs That Contain Gadolinium Riskier for Kidney Patients

by Dr. Shezad Malik

The U.S. Food & Drug Administration is weighing further regulation of three drugs used to create high-contrast images on MRI scans, based on a new analysis that suggests they carry a higher risk of causing a rare, but potentially fatal disease.

The issue, marks a setback for GE Healthcare (GE), which contends that its product is no riskier than competing imaging drugs. FDA reviewers said GE’s drug, Omniscan, had a disproportionately high number of reports of the disease compared with its peers.

December 5, 2009

Public Citizen Asks FDA to Ban Weight Loss Pill

by Dr. Shezad Malik

A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death.

A letter Thursday from Public Citizen calls on the Food and Drug Administration to pull Abbott Laboratories’ drug from the U.S. market, where it is used by roughly a quarter million people.

Preliminary results from a 10,000-patient study — known as the SCOUT study — showed a slightly higher risk of heart-related problems in patients taking Meridia, also called sibutramine, compared with a dummy pill. Patients in the study were older than 55, overweight with a history of heart disease or diabetes.

December 4, 2009

Asbestos Mesothelioma Payout System is Being Questioned

by Dr. Shezad Malik

Once upon a time, asbestos was practically everywhere. Because the material causes devastating forms of cancer and lung disease, huge product-liability litigation sprung up. That led to huge settlements, which led to the establishment of huge trusts, created to assure payment to millions of current and future claimants.

Some $20 billion now resides in these 40 or so trusts, set up by Johns Manville Corp., Owens Corning and other former makers and sellers of asbestos. But who’s overseeing the trusts? Is the money getting spent properly? In short, are the trusts working as designed?

December 3, 2009

Supreme Court Allows $82.6M Award in SUV Rollover

by Dr. Shezad Malik

The Supreme Court has left in place an $82.6 million award to a woman who was paralyzed after her Ford Explorer rolled over.

The justices rejected Ford Motor Co.’s challenge to the portion of the award, $55 million, that was intended as punitive damages. Ford argued that it should not be punished because its design of the vehicle met federal safety standards.

A California state appeals court earlier rejected Ford’s contention and upheld the award to Benetta Buell-Wilson.

December 1, 2009

WA Supreme Court Reinstates $8M Award Against Hyundai

by Dr. Shezad Malik

The state Supreme Court reinstated an $8 million default judgment against Hyundai Motor Co. in a lawsuit over the backward collapse of a front seat in a 1997 crash that left a man paralyzed.

In a 7-2 ruling, the high court reversed the Court of Appeals, which had overturned a trial court’s finding for Jesse Magana of Vancouver.

The justices said the South Korean automaker deliberately withheld documentation from Magana’s lawyers for too long concerning other crashes in which front seats collapsed backward.

“Trial courts need not tolerate deliberate and willful discovery abuse,” wrote the majority. “This result appropriately compensates the other party, punishes Hyundai, and hopefully educates and deters others so inclined.”

November 30, 2009

Federal Safety Regulators Announce New Crib Recall

by Dr. Shezad Malik

The head of the Consumer Product Safety Commission conceded that the agency “hasn’t been acting as quickly as it should” on crib safety problems.

More than 2.1 million drop-side cribs by Stork Craft Manufacturing of Canada are being recalled following reports of four infant suffocations. The CPSC said the recall involves 1.2 million cribs in the United States and almost 1 million in Canada, where Stork Craft is based. Sales of the cribs being recalled go back to 1993 and nearly 150,000 of the cribs carry the Fisher-Price logo.

November 29, 2009

Federal Lawsuit Dismissed Over Merck’s Fosamax

by Dr. Shezad Malik

A federal judge has dismissed a lawsuit alleging that Merck osteoporosis drug Fosamax causes jaw damage, more than two months after a jury deadlocked in a case involving a similar claim.

U.S. District Judge John Keenan found that Bessie Flemings, 74, a Mississippi resident, failed to present enough evidence to show that her use of Fosamax caused osteonecrosis of the jaw, or the death of jawbone tissue.

Keenan said Flemings’ case was the second “bellwether” trial in nationwide litigation over Fosamax, which has spawned close to 900 lawsuits.

November 26, 2009

Philip Morris Ordered to Pay $300 M to Smoker

by Dr. Shezad Malik

A Florida jury ordered cigarette maker Philip Morris USA to pay $300 million in damages to a 61-year-old ex-smoker named Cindy Naugle who is wheelchair-bound by emphysema.

The Broward Circuit Court jury assessed $56.6 million in past and future medical expenses against the company, part of Altria Group Inc, as well as $244 million in punitive damages.

The verdict is the largest of the so-called Engle progeny cases that have been tried so far, both sides said.

Philip Morris will seek further review of the verdict because of “numerous erroneous rulings by the trial judge,” Philip Morris spokesman Murray Garnick said in a statement.

November 24, 2009

Pfizer Must Pay $6 M in Damages Over Prempro

by Dr. Shezad Malik

Two Pfizer Inc. units’ hormone- replacement therapy drugs caused an Illinois woman’s breast cancer, making them liable for at least $6.3 million in damages, a Philadelphia jury ruled.

Jurors found that the combination of Wyeth’s Prempro and Pharmacia & Upjohn’s Provera menopause drugs was a substantial contributing factor in Donna Kendall’s breast cancer. Kendall, 66, had a double mastectomy in 2002 after taking the hormone-replacement drugs for 11 years.

The panel will hear evidence Nov. 23 on whether Wyeth and Upjohn should pay punitive damages over their handling of the drugs. Wyeth has lost six of nine jury verdicts, including the last four in a row, over the drugs since 2006. This is Upjohn’s third loss at the jury stage. A trial judge threw out one verdict and another is on appeal.